Skip to main content
  • Feature Story

FDA Announces New Office for Regulating Dietary Supplements

January 14, 2016

UNITED STATES - The U.S. Food and Drug Administration (FDA) announced the creation of the Office of Dietary Supplement Programs (ODSP) as an official division under the Office of Nutrition Labeling and Dietary Supplements. The new division is assigned to the following tasks:

  • Take action to remove from the market supplement products that are dangerous to consumers
  • Work with FDA’s Center for Drug Evaluation and Research to help remove from the market products falsely labeled as dietary supplements that contain potentially harmful pharmaceutical agents
  • Enforce the dietary supplement good manufacturing practices (GMP) regulation, giving priority to cases in which GMP violations:

      o   Potentially compromise product safety
      o   Fail to ensure product identity, potentially jeopardizing consumer safety
      o   Result in consumer deception, when, for example, manufacturers do not verify the identity of their raw materials

  • Take action against claims in cases involving serious risk of harm to the consumer (such as egregious claims of benefit in treating serious diseases) or widespread economic fraud
  •  
    The creation of the new division is made following an increase in dietary supplements issues over the past several years.
     
    Source

    Get in touch

    Have questions, need specifics? Let's get this conversation started.

    Help and support

    How can we help?